Lipid Levels Including Oxidized LDL in Women with History of Preeclampsia

REFERENCES

• Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005 Nov; 46(5):1077–1085.
   PubMed Web of Science ®Google Scholar
• Walker JJ. Pre-eclampsia. Lancet 2000 Oct 7; 356(9237):1260–1265.
   PubMed Web of Science ®Google Scholar
• Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998 Nov; 179(5):1359–1375.
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001 Jun 23; 357(9273):2002–2006.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001 Jan 6; 357(9249):53–56.
   PubMed Web of Science ®Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002 Jul 20; 325(7356):157–160.
   PubMed Web of Science ®Google Scholar
• Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997 Feb; 77(2):154–158.
   PubMed Web of Science ®Google Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001 Nov 24; 323(7323):1213–1217.
   PubMed Web of Science ®Google Scholar
• Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995 Nov; 74(10):772–776.
   PubMed Web of Science ®Google Scholar
• Belo L, Caslake M, Gaffney D, Santos-Silva A, Pereira-Leite L, Quintanilha A, Rebelo I. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002 Jun; 162(2):425–432.
   PubMedGoogle Scholar
• Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baumstark MW, Zahradnik HP, Wieland H, Marz W. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 2003 Mar; 88(3):1162–1166.
   PubMedGoogle Scholar
• Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 1996 Feb; 37(2):299–308.
   PubMed Web of Science ®Google Scholar
• Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol 1992 Jun 16; 45(1):27–35.
   PubMed Web of Science ®Google Scholar
• Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int J Gynaecol Obstet 1999 Dec; 67(3):147–155.
   PubMed Web of Science ®Google Scholar
• Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992 Aug; 167(2):440–447.
   PubMedGoogle Scholar
• Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997 Mar; 89(3):403–408.
   PubMed Web of Science ®Google Scholar
• Belo L, Santos-Silva A, Caslake M, Pereira-Leite L, Quintanilha A, Rebelo I. Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size. Atherosclerosis 2005 Nov; 183(1):185–186. Epub 2005 Aug 1
   PubMedGoogle Scholar
• Ozan H, Ilçöl Y, Kimya Y, Cengiz C, Ediz B. Plasma anti-oxidant status and lipid profile in non-gravida women with a history of pre-eclampsia. J Obstet Gynaecol Res 2002 Oct; 28(5):274–279.
   PubMedGoogle Scholar
• Girouard J, Giguère Y, Moutquin JM, Forest JC. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007 May; 49(5):1056–1062. Epub 2007 Mar 26
   PubMedGoogle Scholar
• Forest JC, Girouard J, Massé J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguère Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005 Jun; 105(6):1373–1380.
   PubMed Web of Science ®Google Scholar
• Gratacós E, Casals E, Gómez O, Llurba E, Mercader I, Cararach V, Cabero L. Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia. BJOG 2003 Apr; 110(4):400–404.
   PubMed Web of Science ®Google Scholar
• Qiu C, Phung TT, Vadachkoria S, Muy-Rivera M, Sanchez SE, Williams MA. Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiol Res 2006; 55(5):491–500.
   PubMed Web of Science ®Google Scholar
• Li D, Mehta JL. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction. Endothelium 2003; 10(1):17–21.
   PubMed Web of Science ®Google Scholar
• Uzun H, Benian A, Madazli R, Topçuoğlu MA, Aydin S, Albayrak M. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 2005; 60(4):195–200. Epub 2005 Jul 26
   PubMedGoogle Scholar
• Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 1999 Sep 4; 354(9181):788–789.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16(1):5–15.
   PubMedGoogle Scholar
• Rogers RG, Thorp JMJr.. Pregnancy-induced hypertension: genesis of and response to endothelial injury and the role of endothelin 1. Obstet Gynecol Surv 1997 Dec; 52(12):723–727.
   PubMedGoogle Scholar
• Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN, Michael CA. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci (Lond) 1997 Jan; 92(1):37–44.
   PubMedGoogle Scholar
• Islami D, Shoukir Y, Dupont P, Campana A, Bischof P. Is cellular fibronectin a biological marker for pre-eclampsia?. Eur J Obstet Gynecol Reprod Biol 2001 Jul; 97(1):40–45.
   PubMedGoogle Scholar
• . Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998 Dec; 179(6 Pt 1):1605–1611.
   PubMed Web of Science ®Google Scholar
• Bellart J, Gilabert R, Anglès A, Piera V, Miralles RM, Monasterio J, Cabero L. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999 Jun; 106(6):594–597.
   PubMedGoogle Scholar
• Forest JC, Girouard J, Massé J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguère Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005 Jun; 105(6):1373–1380.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Park H, Lee HY, Ahn YM, Ha EH, Suh SH, Pang MG. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007 Jul; 133(1):47–52.
   PubMedGoogle Scholar
• Sanchez SE, Williams MA, Muy-Rivera M, Qiu C, Vadachkoria S, Bazul V. A case-control study of oxidized low density lipoproteins and preeclampsia risk. Gynecol Endocrinol 2005 Oct; 21(4):193–199.
   PubMed Web of Science ®Google Scholar
• Hörkkö S, Binder CJ, Shaw PX, Chang MK, Silverman G, Palinski W, Witztum JL. Immunological responses to oxidized LDL. Free Radic Biol Med 2000 Jun 15; 28(12):1771–1779.
   PubMed Web of Science ®Google Scholar